JP4391856B2 - Caries risk inspection tool - Google Patents

Caries risk inspection tool Download PDF

Info

Publication number
JP4391856B2
JP4391856B2 JP2004049331A JP2004049331A JP4391856B2 JP 4391856 B2 JP4391856 B2 JP 4391856B2 JP 2004049331 A JP2004049331 A JP 2004049331A JP 2004049331 A JP2004049331 A JP 2004049331A JP 4391856 B2 JP4391856 B2 JP 4391856B2
Authority
JP
Japan
Prior art keywords
porous membrane
antibody
specimen
caries risk
caries
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004049331A
Other languages
Japanese (ja)
Other versions
JP2005241335A (en
Inventor
諭美子 鱒沢
敦史 立野
裕樹 内藤
佳子 渡邊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Corp
Original Assignee
GC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GC Corp filed Critical GC Corp
Priority to JP2004049331A priority Critical patent/JP4391856B2/en
Publication of JP2005241335A publication Critical patent/JP2005241335A/en
Application granted granted Critical
Publication of JP4391856B2 publication Critical patent/JP4391856B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Description

本発明は、免疫クロマトグラフィー法を用い口腔内細菌に起因する要因と宿主に起因する要因との二方面から総合的にう蝕のリスクを検査するう蝕リスク検査用具に関するものである。   The present invention relates to a caries risk testing tool for comprehensively examining caries risk from the two aspects of factors attributable to oral bacteria and factors attributable to a host using an immunochromatography method.

近年、う蝕の進行を抑制する対策を考えたり、う蝕の治療計画を立てるために歯科医療術者が患者のう蝕リスクを把握しようという動きが起き始めている。う蝕は口腔内の状況や生活習慣等に起因する多因子性の疾患であり「口腔内細菌」,「宿主」及び「食物」の三要因が揃うことで発症することが知られている(例えば、非特許文献1参照)。患者自身にう蝕リスクを理解させることは、オーラルケアの維持継続に対して動機を与える上でも重要なことである。   In recent years, dentistry surgeons have begun to try to grasp the caries risk of patients in order to consider measures to suppress the progression of caries and to make caries treatment plans. It is known that caries is a multifactorial disease caused by oral conditions and lifestyle habits and develops when all three factors of "oral bacteria", "host" and "food" are combined ( For example, refer nonpatent literature 1). Having the patient understand the caries risk is also important to motivate the maintenance of oral care.

特に口腔内細菌とう蝕の発症との間には密接な関係があることが知られており、口腔内細菌の一種であるミュータンス連鎖球菌の数が多いほどう蝕が発症する確率が高いことが報告されてからミュータンス連鎖球菌の数を簡易に定量し、う蝕リスクを把握しようとする試みが数多く行われてきた。ヒトの唾液中に存在するミュータンス連鎖球菌の数を簡易に定量する方法としては、ミュータンス連鎖球菌の一種であるストレプトコッカス・ミュータンスに特異的に反応するモノクロ−ナル抗体を応用して定量しようとするもの(例えば、特許文献1及び2参照。)や、簡易培養キットで増殖した菌体そのものを目視により定量するもの等がある(例えば、特許文献3参照。)。   In particular, it is known that there is a close relationship between oral bacteria and the development of dental caries, and the higher the number of mutans streptococcus, a kind of oral bacteria, the higher the probability of developing dental caries. Since then, many attempts have been made to easily determine the number of mutans streptococci and understand the caries risk. A simple method for quantifying the number of Streptococcus mutans in human saliva is to apply a monoclonal antibody that reacts specifically with Streptococcus mutans, a type of Streptococcus mutans. (For example, refer to Patent Documents 1 and 2) and those for visually quantifying the cells grown in a simple culture kit (for example, refer to Patent Document 3).

また、「宿主」の観点からう蝕リスクを把握する方法としては、例えば唾液の分泌量や唾液の緩衝能等の測定が一般的に行われてきたが、近年ストレプトコッカス・ミュータンス菌の体表層物質の一部である特定のタンパク質が、歯面に対するストレプトコッカス・ミュータンス菌の初期付着に関連があることが確認され、特定のタンパク質を抗原としてその抗体となる物質を探求したところ、口腔粘膜から唾液中へ分泌される分泌型免疫グロブリン抗体A(以下SIgAと記す)が歯面に対するストレプトコッカス・ミュータンス菌の付着を防御する機能を持つことが解明された。即ち、ヒトの唾液中におけるSIgAの抗体価が高いと歯面に対してストレプトコッカス・ミュータンス菌が付着し難く、う蝕リスクが低いことが究明されう蝕リスク検査方法として提案されている(特許文献4参照。)。   In addition, as a method for grasping caries risk from the viewpoint of “host”, for example, saliva secretion amount and saliva buffering capacity have been generally measured, but in recent years, the surface layer of Streptococcus mutans bacteria A specific protein that is a part of the substance was confirmed to be related to the initial adhesion of Streptococcus mutans to the tooth surface. It was elucidated that secretory immunoglobulin antibody A (hereinafter referred to as SIgA) secreted into saliva has a function of protecting the adhesion of Streptococcus mutans to the tooth surface. That is, it has been proposed as a caries risk test method that has been found that Streptococcus mutans bacteria hardly adhere to the tooth surface when the antibody titer of SIgA in human saliva is high, and that the caries risk is low (patent) Reference 4).

しかしながら、これらのう蝕リスク検査は「口腔内細菌」や「宿主」等の各々の要素毎に行われていたため、本来う蝕は多因子性の疾患であるにも関わらず種々の要素に関するリスクから総合的なリスクを判断することが難しいという問題があった。また、一般的に免疫クロマトグラフィー法を用いてう蝕リスクを検査する際、う蝕リスクが高いことを示す場合にも低いことを示す場合にも、その判定結果が赤色系の線で示されることが多く検査を受けた患者は自分のう蝕リスクが高いのか若しくは低いのかを一目で理解することが困難であった。   However, since these caries risk tests were performed for each element such as “bacteria in the mouth” and “host”, the risks associated with various factors despite the fact that caries are inherently a multifactorial disease. There was a problem that it was difficult to judge the overall risk from. In general, when examining caries risk using an immunochromatography method, the determination result is indicated by a red line, whether the caries risk is high or low. Often, patients who have been tested often have difficulty understanding at a glance whether their caries risk is high or low.

KeyesPH : Recent advances in dental caries research, bacteriology, bacteriological findings, and biological implications, Int Dent J 1962;12:443KeyesPH: Recent advances in dental caries research, bacteriology, bacteriological findings, and biological implications, Int Dent J 1962; 12: 443 特開平2-177898号公報Japanese Unexamined Patent Publication No. 2-177898 特開平10-36400号公報Japanese Patent Laid-Open No. 10-36400 米国特許5374538号公報US Patent 5374538 特願2002-273125号Japanese Patent Application No. 2002-273125

本発明は、ヒトのう蝕リスクを把握する際に口腔内細菌と宿主の二方面から総合的にう蝕リスクを判断することが可能であり、且つ検査を受けた患者が自分のう蝕リスクを一目で理解することが可能な免疫クロマトグラフィー法を用いたう蝕リスク検査用具を提供することを課題とする。   The present invention is capable of comprehensively judging the caries risk from the two aspects of oral bacteria and host when grasping the human caries risk, and the patient who has undergone the examination has its own caries risk. It is an object of the present invention to provide a caries risk test tool using an immunochromatography method capable of understanding at a glance.

即ち本発明は、長さを持つ二種の多孔質膜片(X)及び多孔質膜片(Y)とが非吸収性の素材から成る基材(Z)に固定されているう蝕リスク検査用具であって、多孔質膜片(X)は、その片端にストレプトコッカス・ミュータンス菌と特異的に結合する抗体(A’)が赤色系の着色粒子(Pr)を付着された状態で含まれた検体滴下部(X)が配置されており、中程にストレプトコッカス・ミュータンス菌と特異的に結合する抗体(A’)とは異なる抗体(A)が含まれた検出部(X)が配置されており、該検出部(X)を挟んで検体滴下部(X)と反対側の端に検体吸収部(X)が配置されており、
多孔質膜片(Y)は、その片端にヒトの唾液中に分泌されるSIgAと特異的に結合する抗体(B)が青色系の着色粒子(Pb)を付着された状態で含まれた検体滴下部(Y)が配置されており、中程にヒトの唾液中に分泌されるSIgAと特異的に結合する抗原(S)が含まれた検出部(Y)が配置されており、該検出部(Y)を挟んで検体滴下部(Y)と反対側の端に検体吸収部(Y)が配置されていることを特徴とするう蝕リスク検査用具である。
That is, the present invention is a caries risk test in which two types of porous membrane pieces (X) having a length and a porous membrane piece (Y) are fixed to a base material (Z) made of a non-absorbable material. The porous membrane piece (X) includes an antibody (A ′) that specifically binds to Streptococcus mutans on one end of the porous membrane piece (X) attached with red colored particles (Pr). The specimen dropping section (X 1 ) is arranged, and the detection section (X 2 ) containing an antibody (A) different from the antibody (A ′) that specifically binds to Streptococcus mutans bacteria in the middle. Is disposed, and a sample absorption part (X 3 ) is disposed at an end opposite to the sample dropping part (X 1 ) across the detection part (X 2 ),
The porous membrane piece (Y) is a specimen in which an antibody (B) that specifically binds to SIgA secreted into human saliva is attached to one end thereof with blue colored particles (Pb) attached thereto. A dropping part (Y 1 ) is arranged, and a detecting part (Y 2 ) containing an antigen (S) that specifically binds to SIgA secreted in human saliva is arranged in the middle, The dental caries risk test tool is characterized in that a specimen absorption part (Y 3 ) is arranged at an end opposite to the specimen dropping part (Y 1 ) across the detection part (Y 2 ).

本発明に係るう蝕リスク検査用具は、一つのう蝕リスク検査用具で口腔内細菌と宿主との二方面から総合的にリスクを判断することが可能であり、更にヒトの唾液中に存在するストレプトコッカス・ミュータンス菌の数が多くう蝕リスクが高い場合には赤色系の染み、ヒトの唾液中に分泌されるSIgAが多くう蝕リスクが低い場合には青色系の染みが現れるため患者自身が自分のう蝕リスクの高低を視覚的にも理解し易いう蝕リスク検査用具である。   The caries risk test tool according to the present invention is capable of comprehensively judging the risk from the two aspects of oral bacteria and host with one caries risk test tool, and further exists in human saliva. If the number of Streptococcus mutans is high and the risk of dental caries is high, the red stain, and if there is a large amount of SIgA secreted in human saliva and the caries risk is low, a blue stain appears. Is a caries risk test tool that makes it easy to visually understand the level of caries risk.

以下、図面を用い本発明に係るう蝕リスク検査用具について詳細に説明するが、本発明は本実施例に限定されるものではない。   Hereinafter, although the caries risk test | inspection tool based on this invention is demonstrated in detail using drawing, this invention is not limited to a present Example.

図1は、二種の多孔質膜片X及び多孔質膜片Yとがそれぞれ一つずつ非吸収性の素材から成る基材Zに固定されているう蝕リスク検査用具の一実施例を模式的に示す斜視説明図である。   FIG. 1 schematically shows an embodiment of a caries risk inspection tool in which two types of porous membrane pieces X and porous membrane pieces Y are fixed to a base material Z made of a non-absorbable material. FIG.

図1の図面中Zは、二種の多孔質膜片X及び多孔質膜片Yとが固定されている基材である。基材Zは非吸収性の素材から成り、例えば、ポリスチレン,ポリエステル,酢酸セルロース等から形成されたものが使用できる。その形状としては、フィルム状,板状,帯状,短冊状,円盤状等いずれでも良いが、多孔質膜を安定して設置するには0.1〜5mm程度の厚みの有る板状が好ましい。   In FIG. 1, Z is a base material on which two kinds of porous membrane pieces X and porous membrane pieces Y are fixed. The substrate Z is made of a non-absorbable material, and for example, a material formed from polystyrene, polyester, cellulose acetate or the like can be used. The shape may be any of a film shape, a plate shape, a strip shape, a strip shape, a disc shape, and the like, but a plate shape having a thickness of about 0.1 to 5 mm is preferable for stably installing the porous membrane.

図1の図面中X及びYは多孔質膜片であり、唾液が毛細管現象によって多孔質膜中を展開されるには多孔質膜片の形状は長方形等長さを持つ形状であることが好ましいが、角が丸みを帯びた長円であったり、周辺が直線ではなく曲線であっても良い。その材質としては、例えば、セルロース膜,酢酸セルロース膜またはニトロセルロース等のセルロース膜誘導体膜、ガラスフィルター、濾紙等が使用できる。多孔質膜片Xと多孔質膜片Yは形状や材質が同じであっても異なっていてもよく、基材Zへの固定は常法によって行うことができ、例えば、両面テープや接着剤を用いて固定すれば良い。固定する際の多孔質膜片X及び多孔質膜片Yの配置の仕方は特に限定されないが、図1に示したように多孔質膜片Xと多孔質膜片Yとが長手方向に平行な位置関係になるように配置すると安定感があって良い。また、多孔質膜X及びYはそれぞれ複数あっても良く、その場合は検査の精度向上が期待できたり検査の効率向上が期待できる。   In the drawing of FIG. 1, X and Y are porous membrane pieces, and the shape of the porous membrane pieces is preferably a shape having a rectangular equal length in order for saliva to be developed in the porous membrane by capillary action. However, it may be an ellipse with rounded corners, or the periphery may be a curved line instead of a straight line. As the material, for example, a cellulose membrane, a cellulose acetate membrane or a cellulose membrane derivative membrane such as nitrocellulose, a glass filter, a filter paper or the like can be used. The porous membrane piece X and the porous membrane piece Y may be the same or different in shape and material, and can be fixed to the substrate Z by a conventional method. For example, a double-sided tape or an adhesive is used. Use and fix. The arrangement of the porous membrane piece X and the porous membrane piece Y at the time of fixing is not particularly limited, but the porous membrane piece X and the porous membrane piece Y are parallel to the longitudinal direction as shown in FIG. There may be a sense of stability when arranged in a positional relationship. Further, there may be a plurality of porous films X and Y. In that case, improvement in inspection accuracy can be expected, and improvement in inspection efficiency can be expected.

図1中のXは検体滴下部、Xは検出部、Xは検体吸収部であり、多孔質膜片Xにおいて検体滴下部Xと検体吸収部Xとは検出部Xを挟んで反対側の端へクリップ等を用いて固定すれば良い。検体吸収部Xは滴下された唾液を吸収しやすい素材であれば特に限定されず例えば濾紙等が使用できる。 In FIG. 1, X 1 is a specimen dropping part, X 2 is a detection part, X 3 is a specimen absorption part, and in the porous membrane piece X, the specimen dropping part X 1 and the specimen absorption part X 3 are the detection part X 2 . What is necessary is just to fix to the edge on the opposite side by using a clip or the like. Sample absorbing section X 3 particularly limited without example filter paper or the like as long as material that easily absorbs dropped saliva can be used.

検体滴下部Xには抗体A’が、検出部Xには抗体Aが含まれている。抗体A’と抗体Aは、歯科用診断や研究用基剤で通常用いられる方法で調製されたストレプトコッカス・ミュータンス菌と特異的に結合する抗体であれば特に限定されないが、抗体Aと抗体A’は種類が異なることが必要である。検体滴下部Xに含まれる抗体A’には金コロイド粒子(British Biocell International社製)等の赤色系の着色粒子Prが付着されている。 The specimen dropping part X 1 contains the antibody A ′, and the detection part X 2 contains the antibody A. The antibody A ′ and the antibody A are not particularly limited as long as they specifically bind to Streptococcus mutans prepared by a method commonly used in dental diagnosis and research bases. 'Need different types. The antibody A 'included in the sample dropping portion X 1 reddish colored particle Pr such as gold colloidal particles (manufactured by British Biocell International, Inc.) is attached.

赤色系の着色粒子Prは、通常免疫クロマトグラフィー法で用いられるものの中で抗体の活性を妨げない赤色系を示す物質であれば特に限定されず、赤色系は市販品等マンセル色相環でいう5RP 10RP 5R 10R 5YR等を示し、中でも10RP 5R 10Rのような色調を示す粒子が好ましい。   The red colored particle Pr is not particularly limited as long as it is a substance exhibiting a red color that does not interfere with the activity of the antibody among those usually used in immunochromatography, and the red color is a commercially available product such as a 5RP 10RP 5R 10R 5YR and the like, and among them, particles exhibiting a color tone such as 10RP 5R 10R are preferable.

検出部Xに含まれる抗体Aは、必要に応じてウシ血清アルブミン含有リン酸緩衝液等で希釈し、例えば図1のように多孔質膜Xの長手方向と垂直になるようマイクロピペットで塗布して多孔質膜Xに固定して使用される。 Antibodies A included in the detection section X 2 are optionally diluted with bovine serum albumin-containing phosphate buffer or the like, for example, coating a porous membrane X longitudinal direction micropipette so that the vertical as shown in Figure 1 Thus, it is used by being fixed to the porous membrane X.

図1中のYは検体滴下部、Yは検出部、Yは検体吸収部であり、多孔質膜片Xと同様に検体滴下部Yと検体吸収部Yとは検出部Yを挟んで反対側の端へクリップ等を用いて固定すれば良い。検体吸収部Yは滴下された唾液を吸収しやすい素材であれば特に限定されず例えば濾紙等が使用できる。 In FIG. 1, Y 1 is a specimen dropping part, Y 2 is a detection part, and Y 3 is a specimen absorption part. Like the porous membrane piece X, the specimen dropping part Y 1 and the specimen absorption part Y 3 are the detection part Y. What is necessary is just to fix to the opposite end on both sides of 2 using a clip or the like. Sample absorbing section Y 3 is particularly limited without example filter paper or the like as long as material that easily absorbs dropped saliva can be used.

検体滴下部Yにはヒトの唾液中に分泌されるSIgAと特異的に結合する抗体Bが、検出部Yにはヒトの唾液中に分泌されるSIgAの抗原Sが含まれている。ヒトの唾液中に分泌されるSIgAと特異的に結合する抗体Bは、歯科用診断や研究用で通常用いられる方法で調製された抗体であれば特に限定されずに使用でき、青色系の着色粒子Pbが付着されている。図1に示されたう蝕リスク検査用具の場合には、ヒトの唾液中に分泌されるSIgAと特異的に結合する抗体B(MONOCLONAL ANTI-HUMAN IGA(SIGMA社製))には青色系粒子Pbとして青色ラテックス粒子(Merck Chimie S.A.S社製)が1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide Hydrochlorideを用いて付着されている。 The sample dripping section Y 1 antibody B which SIgA specifically binds secreted in human saliva, the detection unit Y 2 contains antigen S of SIgA secreted in human saliva. The antibody B that specifically binds to SIgA secreted in human saliva can be used without particular limitation as long as it is an antibody prepared by a method commonly used for dental diagnosis and research, and is colored blue Particles Pb are attached. In the case of the caries risk test tool shown in FIG. 1, blue particles are used for antibody B (MONOCLONAL ANTI-HUMAN IGA (manufactured by SIGMA)) that specifically binds to SIgA secreted in human saliva. Blue latex particles (manufactured by Merck Chimie SAS) are attached as Pb using 1-Ethyl-3- (3-dimethylaminopropyl) carbodiimide Hydrochloride.

検出部Xに含まれるSIgAの抗原Sとしては、例えば、PAc(Protein Antigen cerotype C)(361-386)とよばれるタンパク質を使用でき、SIgAの抗原として機能すれば特に限定されず使用することができる。抗原Sは、必要に応じてリン酸緩衝液等で希釈し、例えば図1のように多孔質膜Yの長手方向と垂直になるようマイクロピペットで塗布して多孔質膜Yに固定して使用される。 Antigens S of SIgA included in the detection section X 2, for example, can use a protein called PAc (Protein Antigen cerotype C) ( 361-386), the use is not limited particularly if functions as an antigen SIgA Can do. Antigen S is diluted with a phosphate buffer or the like as necessary, and applied with a micropipette so as to be perpendicular to the longitudinal direction of porous membrane Y as shown in FIG. Is done.

青色系の着色粒子Pbは、通常免疫クロマトグラフィー法で用いられる着色粒子であって抗体の活性を妨げない物質であれば特に限定されず、青色系としてはマンセル色相環でいう10P 5P 10PB 5PB 10B 5B 10BG 5BG 10G 5G 10GY 5GY等を示し、中でも5PB 10B 5B 10BG 5BG 10G 5G 10GYのような色調をもつ粒子が好ましい。   The blue colored particles Pb are not particularly limited as long as they are colored particles that are usually used in immunochromatography and do not interfere with the activity of the antibody. The blue colored particles are 10P 5P 10PB 5PB 10B 5B 10BG 5BG 10G 5G 10GY 5GY etc. are shown, and among them, particles having a color tone such as 5PB 10B 5B 10BG 5BG 10G 5G 10GY are preferable.

図1に示した二種の多孔質膜片X及び多孔質膜片Yとが非吸収性の素材から成る基材Zに固定されているう蝕リスク検査用具を用いてう蝕リスクを検査する方法を説明する。多孔質膜片Xの検体滴下部Xにヒトの唾液を滴下すると、ヒトの唾液中にストレプトコッカス・ミュータンス菌が存在すれば、ストレプトコッカス・ミュータンス菌は検体滴下部Xに含まれている赤色系の着色粒子Prが付着された抗体A’と結びつき、その結びついた状態で多孔質膜片X中を毛細管現象によって検体滴下部Xから検体吸収部Xへ移動して行く。移動の途中で検出部Xを通過する際にストレプトコッカス・ミュータンス菌は多孔質膜片Xに固定された抗体Aにより補足され、ヒトの唾液中に存在するストレプトコッカス・ミュータンス菌の数が多ければ(う蝕リスクが高ければ)多孔質膜片X上の検出部Xに赤色の染みとして現れる。 The caries risk is inspected using the caries risk inspection tool in which the two kinds of porous film pieces X and porous film pieces Y shown in FIG. 1 are fixed to the base material Z made of a non-absorbable material. A method will be described. Added dropwise and the porous membrane pieces saliva sample dropping portion X 1 of the human X, if there is Streptococcus mutans in human saliva, Streptococcus mutans is included in the sample dropping portion X 1 red colored particles Pr is been combine with antibody a 'attachment, moves the porous membrane piece in X in its associated state from the specimen dropping unit X 1 to the sample absorbing section X 3 by a capillary phenomenon. Streptococcus mutans bacteria when passing through the detecting section X 2 in the middle of the movement is supplemented by antibody A which is fixed to the porous membrane strip X, greater the number of Streptococcus mutans present in human saliva if (if caries risk is high) appears as a red stain detector X 2 on the porous membrane strip X.

同様に、多孔質膜片Yの検体滴下部Yにヒトの唾液を滴下すると、ヒトの唾液中にSIgAが存在すれば、SIgAは検体滴下部Xに含まれている青色系の着色粒子Pbが付着された抗体Bと結びつき、結合した状態で多孔質膜片Y中を毛細管現象によって検体滴下部Yから検体吸収部Yへ移動して行き、移動の途中で検出部Yを通過する際にSIgAは固定された抗原Sにより補足されヒトの唾液中に存在するSIgAが多ければ(う蝕リスクが低ければ)多孔質膜片Y上に青色の染みとして現れる。このようにそれぞれに現れた染みの色を目視で判断して患者のう蝕リスクを判定するのである。 Similarly, dropping the porous membrane pieces saliva sample dropping portion Y 1 of the human Y, if present SIgA in human saliva, the blue SIgA is contained in the sample dropping portion X 1 colored particles Pb ties and attached antibody B, and porous membrane strip in Y in a state bound by navigating from the sample dropping portion Y 1 by capillary action to the sample absorbing section Y 3, the detection unit Y 2 in the middle of the movement When passing, SIgA is captured by the immobilized antigen S, and if SIgA present in human saliva is large (if the caries risk is low), it appears as a blue stain on the porous membrane piece Y. In this way, the color of the stain that appears on each of them is visually judged to determine the caries risk of the patient.

本発明におけるう蝕リスク検査用具を用いて検査する際に用いる唾液は、通常歯科用診断で唾液の検査と同様の方法によって調製され、また必要に応じて調製しておくこともできる。例えばストレプトコッカス・ミュータンス菌数の測定では刺激唾液を、1mol/LのNaOHを含む溶液及び5%のポリオキシエチレン(10)オクチルフェニルエーテルを含有する0.5mol/Lのクエン酸を含む溶液で処理したり、SIgA抗体価の測定では刺激唾液を1%Tween20-0.5%スキムミルクを含むPBSで10倍希釈する等して使用できる。   The saliva used in the examination using the caries risk examination tool of the present invention is usually prepared by the same method as the examination of saliva in a dental diagnosis, and can also be prepared as necessary. For example, when measuring the number of Streptococcus mutans bacteria, stimulated saliva is treated with a solution containing 1 mol / L NaOH and a solution containing 0.5 mol / L citric acid containing 5% polyoxyethylene (10) octylphenyl ether. In the measurement of SIgA antibody titer, the stimulated saliva can be diluted 10 times with PBS containing 1% Tween20-0.5% skim milk.

また、多孔質膜片Xの検体滴下部Xと多孔質膜片Yの検体滴下部Yへ滴下される唾液が各々異なる調製をされている場合には、検体滴下部Xと検体滴下部Yとを異なる形にしたり、異なる記号や数字を記す等しておくと、滴下する唾液を間違える虞がなくより好ましい。 Further, when the saliva is dropped to the sample dropping portion Y 1 of the sample dropping portion X 1 of the porous membrane strip X and the porous membrane pieces Y are each different preparation, sample dropping portion X 1 and sample dropping or a part Y 1 in different shapes, the previously equal mark the different symbols, numbers, and more preferably no fear that wrong saliva dripping.

目視で判断した結果からう蝕リスク判定する際、表1のようなリスク判定表を予め作成しておくと、患者への説明も容易となり更に好ましい。表1中ではストレプトコッカス・ミュータンス菌は虫歯菌と表現している。   When a caries risk is determined from the result of visual determination, it is more preferable that a risk determination table as shown in Table 1 is prepared in advance because the explanation to the patient is easy. In Table 1, Streptococcus mutans bacteria are expressed as caries.

Figure 0004391856
Figure 0004391856

本発明に係るう蝕リスク検査用具の応用例としては、検体滴下部Xにストレプトコッカス・ミュータンス菌と特異的に結合する抗体A’を赤色系の着色粒子Prを付着された状態で含ませておく代わりに、う蝕リスク検査用具外で赤色系の着色粒子Prを付着された抗体A’を含む溶液とヒトの唾液とを混合してから検体滴下部Xに滴下する方法もできる。同様に、検体滴下部Yに青色系のヒトの唾液中に分泌されるSIgAと特異的に結合する抗体Bを青色系の着色粒子Pbを付着された状態で含ませておく代わりに、う蝕リスク検査用具外で青色系の着色粒子Pbを付着された抗体Bを含む溶液とヒトの唾液とを混合してから検体滴下部Yに滴下してう蝕リスクを検査することもできる。 As an application example of caries risk test device according to the present invention is to include antibodies A 'which binds to the analyte dropping unit X 1 Streptococcus mutans specifically in the state where the colored particles Pr is deposited reddish instead keep may method of dropping from a mixture of the saliva of the solution and human containing antibody a 'which is deposited colored particles Pr for red outside caries risk test device to the sample dropping portion X 1. Similarly, instead of including the antibody B that specifically binds to SIgA secreted in the blue human saliva in the specimen dropping part Y 1 with the blue colored particles Pb attached thereto, it is also possible to inspect the caries risk dropwise after mixing the saliva solution and human containing antibody B which is deposited colored particles Pb for blue in the sample dropping portion Y 1 in corrosion risk testing tool out.

更に異なる本発明に係るう蝕リスク検査用具の応用例としては、基材Zに固定される多孔質膜片を1つにして、その片端の検体滴下部にストレプトコッカス・ミュータンス菌と特異的に結合する赤色系の着色粒子Prを付着された抗体A’とヒトの唾液中に分泌されるSIgAと特異的に結合する青色系の着色粒子(Pb)が付着された抗体Bとが同時に含まれ、中程にストレプトコッカス・ミュータンス菌と特異的に結合する抗体A’とは異なる抗体Aとヒトの唾液中に分泌されるSIgAの抗原Sとが間隔を開けて含まれている形態のう蝕リスク検査用具も考えられる。   Furthermore, as an application example of the caries risk inspection tool according to the present invention, a porous membrane piece fixed to the substrate Z is used as one piece, and the specimen dropping part at one end thereof is specifically different from Streptococcus mutans. The antibody A ′ to which the red colored particles Pr to be bound are attached and the antibody B to which blue colored particles (Pb) that specifically bind to SIgA secreted in human saliva are attached are simultaneously included. A caries of a form in which an antibody A different from antibody A ′ that specifically binds to Streptococcus mutans and an antigen S of SIgA secreted in human saliva are contained at intervals. Risk testing tools are also conceivable.

本発明に係るう蝕リスク検査用具の一実施例を模式的に示す斜視説明図。BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a perspective explanatory view schematically showing one embodiment of a caries risk inspection tool according to the present invention.

符号の説明Explanation of symbols

X:多孔質膜X
:検体滴下部
Pr:赤色系着色粒子
A’:ストレプトコッカス・ミュータンス菌と特異的に結合する抗体
:検出部
A:ストレプトコッカス・ミュータンス菌と特異的に結合する抗体
:検体吸収部
Y:多孔質膜Y
:検体滴下部
Pb:青色系着色粒子
B:ヒトの唾液中に分泌されるSIgAと特異的に結合する抗体
:検出部
S:ヒトの唾液中に分泌されるSIgAの抗原
:検体吸収部
Z:基材
X: Porous membrane X
X 1 : Sample dropping part Pr: Red colored particles
A ′: an antibody that specifically binds to Streptococcus mutans bacteria X 2 : detection unit
A: Antibody that specifically binds to Streptococcus mutans X 3 : Specimen absorption part Y: Porous membrane Y
Y 1 : Sample dropping part Pb: Blue colored particles
B: Antibody that specifically binds to SIgA secreted in human saliva Y 2 : Detection unit
S: Antigen of SIgA secreted into human saliva Y 3 : Sample absorption part Z: Base material

Claims (1)

長さを持つ二種の多孔質膜片(X)及び多孔質膜片(Y)とが非吸収性の素材から成る基材(Z)に固定されているう蝕リスク検査用具であって、
多孔質膜片(X)は、その片端にストレプトコッカス・ミュータンス菌と特異的に結合する抗体(A’)が赤色系の着色粒子(Pr)を付着された状態で含まれた検体滴下部(X)が配置されており、中程にストレプトコッカス・ミュータンス菌と特異的に結合する抗体(A’)とは異なる抗体(A)が含まれた検出部(X)が配置されており、該検出部(X)を挟んで検体滴下部(X)と反対側の端に検体吸収部(X)が配置されており、
多孔質膜片(Y)は、その片端にヒトの唾液中に分泌されるSIgAと特異的に結合する抗体(B)が青色系の着色粒子(Pb)を付着された状態で含まれた検体滴下部(Y)が配置されており、中程にヒトの唾液中に分泌されるSIgAと特異的に結合する抗原(S)が含まれた検出部(Y)が配置されており、該検出部(Y)を挟んで検体滴下部(Y)と反対側の端に検体吸収部(Y)が配置されていることを特徴とするう蝕リスク検査用具。














Two types of porous membrane pieces (X) having a length and a porous membrane piece (Y) are caries risk inspection tools fixed to a base material (Z) made of a non-absorbable material,
The porous membrane piece (X) has a specimen dropping part (Red) in which an antibody (A ′) that specifically binds to Streptococcus mutans bacteria is attached to one end of the porous membrane piece (X). X 1 ) is arranged, and a detection part (X 2 ) containing an antibody (A) different from the antibody (A ′) that specifically binds to Streptococcus mutans is arranged in the middle. , The specimen absorption section (X 3 ) is disposed at the end opposite to the specimen dropping section (X 1 ) across the detection section (X 2 ),
The porous membrane piece (Y) is a specimen in which an antibody (B) that specifically binds to SIgA secreted into human saliva is attached to one end thereof with blue colored particles (Pb) attached thereto. A dropping part (Y 1 ) is arranged, and a detecting part (Y 2 ) containing an antigen (S) that specifically binds to SIgA secreted in human saliva is arranged in the middle, A caries risk inspection tool, characterized in that a specimen absorption part (Y 3 ) is arranged at an end opposite to the specimen dropping part (Y 1 ) across the detection part (Y 2 ).














JP2004049331A 2004-02-25 2004-02-25 Caries risk inspection tool Expired - Fee Related JP4391856B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004049331A JP4391856B2 (en) 2004-02-25 2004-02-25 Caries risk inspection tool

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004049331A JP4391856B2 (en) 2004-02-25 2004-02-25 Caries risk inspection tool

Publications (2)

Publication Number Publication Date
JP2005241335A JP2005241335A (en) 2005-09-08
JP4391856B2 true JP4391856B2 (en) 2009-12-24

Family

ID=35023229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004049331A Expired - Fee Related JP4391856B2 (en) 2004-02-25 2004-02-25 Caries risk inspection tool

Country Status (1)

Country Link
JP (1) JP4391856B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5981350B2 (en) 2010-12-28 2016-08-31 ライオン株式会社 Method for determining oral condition, and analysis tool, apparatus, and program used therefor

Also Published As

Publication number Publication date
JP2005241335A (en) 2005-09-08

Similar Documents

Publication Publication Date Title
JP7235735B2 (en) New general-purpose inspection system for quantitative analysis
US6841159B2 (en) Rapid lateral flow assay for determining exposure to Mycobacterium tuberculosis and other mycobacteria
US20190376970A1 (en) Method and Device for Combined Detection of Viral and Bacterial Infections
AU2014226173B2 (en) Method and device for combined detection of viral and bacterial infections
US8962260B2 (en) Method and device for combined detection of viral and bacterial infections
JPH01206258A (en) Immunoassay instrument and immunoassay using the same
Chapman et al. Home allergen monitoring and control–improving clinical practice and patient benefits.
CN106370861A (en) C reactive protein saliva test paper strip and preparation method thereof
Berg et al. The laboratory diagnosis of Lyme disease
EP3726219A1 (en) Method for diagnosing tuberculosis
JP4391856B2 (en) Caries risk inspection tool
JP4065600B2 (en) Immunological assay and immunological assay kit
CN209264735U (en) A kind of high pass amount detecting device for two-step method immunochromatography
Treepongkaruna et al. A rapid serologic test and immunoblotting for the detection of Helicobacter pylori infection in children
Taylor et al. Assessment of laboratory improvement by the Center for Disease Control diagnostic immunology proficiency testing program
JP2008058334A (en) Development solvent, measuring method and kit for immunochromatography
Daga et al. Immunoglobulin isotype compositions of ABO specific antibodies are dependent on the individual patient blood group and blood group specificity: results from a healthy donor cohort
KR101790920B1 (en) Strip for detecting c-reactive protein
JP6716241B2 (en) Method for detecting IgG antibody against periodontal pathogen
JP4176457B2 (en) Sampling tool for dental diseases
US20190232286A1 (en) Assay Device and Method for Assessing Blood Cells
KR20240017711A (en) Rapid diagnostic kit of oral microbiota for adult and the method using the same
KR20240017710A (en) Rapid diagnostic kit of oral microbiota for infant and the method using the same
KR20240017712A (en) Rapid diagnostic device of oral microbiota
Gunnarsson et al. The usefulness of Diffusion-In-Gel-ELISA in clinical practice as illustrated by a Campylobacter jejuni outbreak

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070105

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080905

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091006

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20091008

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121016

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131016

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees